Juan F. Navarro-González
Nephrology Service
University Hospital Nuestra Señora de Candelaria
38010 Santa Cruz de Tenerife
Spain
[email]@gobiernodecanarias.org
Name/email consistency: high
- Effect of Phosphate Binders on Serum Inflammatory Profile, Soluble CD14, and Endotoxin Levels in Hemodialysis Patients. Navarro-González, J.F., Mora-Fernández, C., Muros de Fuentes, M., Donate-Correa, J., Cazaña-Pérez, V., García-Pérez, J. Clin. J. Am. Soc. Nephrol (2011)
- Serum and gene expression profile of tumor necrosis factor-alpha and interleukin-6 in hypertensive diabetic patients: effect of amlodipine administration. Navarro-Gonzalez, J., Mora-Fernandez, C., Gomez-Chinchon, M., Muros, M., Herrera, H., Garcia, J. Int. J. Immunopathol. Pharmacol (2010)
- Tumor necrosis factor-alpha as a therapeutic target for diabetic nephropathy. Navarro-González, J.F., Jarque, A., Muros, M., Mora, C., García, J. Cytokine Growth Factor Rev. (2009)
- Mineral metabolism and inflammation in chronic kidney disease patients: a cross-sectional study. Navarro-González, J.F., Mora-Fernández, C., Muros, M., Herrera, H., García, J. Clin. J. Am. Soc. Nephrol (2009)
- Clinical implications of disordered magnesium homeostasis in chronic renal failure and dialysis. Navarro-González, J.F., Mora-Fernández, C., García-Pérez, J. Semin. Dial (2009)
- Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients. Navarro, J.F., Mora, C., Gómez, M., Muros, M., López-Aguilar, C., García, J. Nephrol. Dial. Transplant. (2008)
- The role of inflammatory cytokines in diabetic nephropathy. Navarro-González, J.F., Mora-Fernández, C. J. Am. Soc. Nephrol. (2008)
- The role of TNF-alpha in diabetic nephropathy: pathogenic and therapeutic implications. Navarro, J.F., Mora-Fernández, C. Cytokine Growth Factor Rev. (2006)
- Diabetes, inflammation, proinflammatory cytokines, and diabetic nephropathy. Navarro, J.F., Mora, C. ScientificWorldJournal (2006)
- Urinary tumour necrosis factor-alpha excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patients. Navarro, J.F., Mora, C., Muros, M., García, J. Nephrol. Dial. Transplant. (2006)
- Renal pro-inflammatory cytokine gene expression in diabetic nephropathy: effect of angiotensin-converting enzyme inhibition and pentoxifylline administration. Navarro, J.F., Milena, F.J., Mora, C., León, C., García, J. Am. J. Nephrol. (2006)
- Additive antiproteinuric effect of pentoxifylline in patients with type 2 diabetes under angiotensin II receptor blockade: a short-term, randomized, controlled trial. Navarro, J.F., Mora, C., Muros, M., García, J. J. Am. Soc. Nephrol. (2005)
- Tumor necrosis factor-alpha gene expression in diabetic nephropathy: relationship with urinary albumin excretion and effect of angiotensin-converting enzyme inhibition. Navarro, J.F., Milena, F.J., Mora, C., León, C., Claverie, F., Flores, C., García, J. Kidney Int. Suppl. (2005)
- Effects of pentoxifylline administration on urinary N-acetyl-beta-glucosaminidase excretion in type 2 diabetic patients: a short-term, prospective, randomized study. Navarro, J.F., Mora, C., Muros, M., Maca, M., Garca, J. Am. J. Kidney Dis. (2003)